Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

ConclusionWe have developed a consensus document with recommendations on the treatment of patients with HER2-negative luminal MBC that will help to improve therapeutic benefits.

Source: Clinical and Translational Oncology - February 11, 2020 Category: Cancer & Oncology Source Type: research